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ABSTRACT Previous studies have shown that membrane tubule–mediated export from en-
dosomal compartments requires a cytoplasmic phospholipase A2 (PLA2) activity. Here we re-
port that the cytoplasmic PLA2 enzyme complex platelet-activating factor acetylhydrolase 
(PAFAH) Ib, which consists of α1, α2, and LIS1 subunits, regulates the distribution and func-
tion of endosomes. The catalytic subunits α1 and α2 are located on early-sorting endosomes 
and the central endocytic recycling compartment (ERC) and their overexpression, but not 
overexpression of their catalytically inactive counterparts, induced endosome membrane tu-
bules. In addition, overexpression α1 and α2 altered normal endocytic trafficking; transferrin 
was recycled back to the plasma membrane directly from peripheral early-sorting endosomes 
instead of making an intermediate stop in the ERC. Consistent with these results, small inter-
fering RNA–mediated knockdown of α1 and α2 significantly inhibited the formation of endo-
some membrane tubules and delayed the recycling of transferrin. In addition, the results 
agree with previous reports that PAFAH Ib α1 and α2 expression levels affect the distribution 
of endosomes within the cell through interactions with the dynein regulator LIS1. These stud-
ies show that PAFAH Ib regulates endocytic membrane trafficking through novel mechanisms 
involving both PLA2 activity and LIS1-dependent dynein function.
INTRODUCTION
Trafficking through the endocytic pathway involves an ordered set 
of transport steps that moves both membrane-bound and soluble 
cargo between different compartments (Bonifacino and Glick, 2004; 
Maxfield and McGraw, 2004). Most endocytic compartments in 
mammalian cells, especially early-sorting endosomes and the endo-
cytic recycling compartment (ERC), are morphologically complex 
tubulovesicular structures consisting of a mosaic of phosphoinositi-
des, regulatory proteins, and other effectors (Marsh et al., 1986; 
Miaczynska and Zerial, 2002; Maxfield and McGraw, 2004; He et al., 
2008). Sorting and export out of endocytic compartments has long 
been recognized to involve membrane tubules that emanate from 
the main vacuolar domain (Geuze et al., 1983b). On the basis of 
geometry alone, thin membrane tubules (60–80 nm in diameter) 
serve as efficient sorting structures to separate membrane lipids and 
proteins from soluble internal contents (Rome, 1985). Early studies 
showed that many itinerant receptors become concentrated into 
tubular domains of endosomes for efficient export (Geuze et al., 
1983a, 1987; Stoorvogel et al., 1987). These tubular extensions may 
function as platforms for the budding of coated vesicles or may de-
tach to serve as trafficking intermediates (Bonifacino and Rojas, 
2006).
The molecular mechanisms that mediate the formation of endo-
some membrane tubules are unclear. Rabs and other molecules 
have been shown to be involved in the formation of tubular do-
mains on endosomes and to function in export from these organ-
elles. For example, sorting nexins (Cullen, 2008) and Rab7 (Rojas 
et al., 2008) facilitate the tubule-mediated sorting of itinerant endo-
cytic cargoes. In addition, pharmacological and biochemical studies 
have suggested that phospholipid remodeling by cytoplasmic 
phospholipase A2 (PLA2) enzymes plays an important role in the 
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fected with hemagglutinin (HA)-tagged α1 and α2 (Bechler et al., 
2010). In addition, we found that α1-HA and α2-HA were located 
on peripheral cytoplasmic puncta that colocalized with the early 
endosome proteins EEA1 and GFP-Rab5 (Figure 1, A and B; Sup-
plemental Figure S1A). At higher magnifications, the mosaic na-
ture of this compartment was revealed, as EEA1 was confined to 
the spherical domain, whereas α1-HA could also be found on tu-
bular extensions (Supplemental Figure S1A). PAFAH Ib α1 and α2 
have conserved lipase motifs, and changing the serine residues in 
these motifs (α1 S47A; α2 S48A) renders the subunits catalytically 
inactive (Hattori et al., 1994). We found that α1 S47A and α2 
S48A were still partially localized to EEA1-positive early-sorting 
endosomes in transfected cells, demonstrating that catalytic ac-
tivity is not required for organelle targeting (Supplemental Figure 
S1B; unpublished data). In addition to peripheral early-sorting 
endosomes, HA-tagged α1 and α2 were found on the centrally 
located ERC, as determined by colocalization with the ERC 
marker GFP-Rab11 (Figure 1, C and D). Localization of α1 or α2 
on late endosomes/lysosomes was not observed (Supplemental 
Figure S1C).
To obtain complementary evidence that α1 and α2 subunits 
bind to endosome and Golgi membranes, we investigated the po-
tential molecular mechanisms responsible for these interactions. It 
is well established that phosphoinositol phosphates (PIPs) serve as 
organelle landmarks and platforms for many cytoplasmic proteins 
that regulate membrane trafficking (Sato et al., 2001). The cyto-
plasmic surface of Golgi membranes is enriched in PI(4)P and en-
dosomes in PI(3)P, which mediate the binding of specific effector 
proteins. Using dot blot (PIP strip) overlays, we found that α1 binds 
specifically to PI(3)P and PI(4)P, and α2 to PI(3)P (Figure 1E). These 
results are consistent with the in vivo localization studies and sug-
gest a mechanism by which α1 and α2 are recruited to endosome 
and Golgi membranes.
Overexpression of α1 or α2 alters the location  
of endocytic compartments
Whereas α1 and α2 were found on early-sorting endosomes and 
recycling endosomes, we observed that the distribution of early and 
late endosomes, but not that of recycling endosomes, was altered 
by overexpression (Figure 2). Both early and late endosomes ap-
peared to be dispersed to the periphery, similar to defects in dy-
nein-dependent endosome transport to the centrosome (Burkhardt 
et al., 1997; Harada et al., 1998; Valetti et al., 1999; Liang et al., 
2004). The overexpression of α1 or α2 has been shown to affect 
LIS1–dynein interactions by sequestering LIS1 away from dynein 
(Yamaguchi et al., 2007), resulting in dispersed membrane organ-
elles (Ding et al., 2009).
To test whether this redistribution is dependent on α1 and α2 
catalytic activity, LIS1 binding, or both, we expressed the catalytic 
mutant α1 S47A, the LIS1-binding mutant α1 E38D (Yamaguchi 
et al., 2007), or the double mutant α1 S47A/E38D. The relative 
expression levels of overexpressed α1 and mutants were compa-
rable (Bechler et al., 2010). The overexpression of both catalyti-
cally active and inactive α1 S47A resulted in a peripheral distribu-
tion of late and early endosomes, whereas expression of the 
LIS1-binding mutant, α1 E38D, had normal endosome distribu-
tion, consistent with previous reports (Ding et al., 2009). Likewise, 
the LIS1-binding-defective and catalytically inactive α1 S47A/
E38D showed normal distribution of early and late endosomes 
(Figure 2). The endocytic recycling compartment, as seen by GFP-
Rab11, appeared unaffected by the expression of α1 or the various 
α1 mutants.
formation of endosome membrane tubules (Brown et al., 2003). For 
example, a broad spectrum of PLA2 antagonists inhibit the forma-
tion of endosome membrane tubules in vivo and in a cytosol-
dependent in vitro reconstitution system (de Figueiredo et al., 2001). 
In addition, these PLA2 antagonists inhibit the export of transferrin 
(Tf) and Tf receptors (TfR) from early-sorting endosomes and the 
ERC. These results strongly suggest that a cytoplasmic PLA2 func-
tions in tubule-mediated export at each of these endosomal com-
partments.
The identity of cytoplasmic PLA2 enzymes involved in the forma-
tion of endosomal membrane tubules has remained elusive. Here 
we show that the catalytic subunits of platelet-activating factor 
acetylhydrolase (PAFAH) Ib are endosome-associated PLA2 enzymes 
that mediate tubule formation and route endocytic receptors for 
recycling. PAFAH Ib was originally purified based on its ability to 
hydrolyze an acetyl group in the sn-2 position of the signal transduc-
tion phospholipid platelet-activating factor (PAF) (Hattori et al., 
1993). It is a multi-subunit complex consisting of a dimer of 
two highly conserved catalytic subunits, α1 (Pafah1b3) and α2 
(Pafah1b2), and an associated noncatalytic subunit, β (Pafah1b1) 
(Arai, 2002). Within a species, α1 and α2 subunits share ∼60% amino 
acid identity and by themselves can form catalytically active ho-
modimers or heterodimers (Manya et al., 1999). The β subunit, also 
known as LIS1, is highly conserved from yeast to humans, and muta-
tions in it lead to the fatal brain disorder Miller–Dieker lissencephaly 
(Kato and Dobyns, 2003). Independent of binding to α1 or α2, LIS1 
regulates the location of dynein on microtubules through the com-
bined activities of a host of accessory proteins, including NudE and 
NudEL (Yamada et al., 2008; Lam et al., 2010). LIS1, NudE, and Nu-
dEL are responsible for nuclear trafficking in yeasts, spindle orienta-
tion, and neuronal migration in mammals, the last being compro-
mised in human lissencephaly (Vallee and Tsai, 2006; Kerjan and 
Gleeson, 2007).
Although PAFAH Ib has been implicated in a wide array of 
processes, its exact biological function is unclear. Mice with tar-
geted disruption of both Pafah1b2 and Pafah1b3 genes (α1−/−/
α2−/−) exhibit defects in spermatogenesis but are otherwise nor-
mal (Koizumi et al., 2003; Yan et al., 2003). In contrast, recent 
studies using overexpression and small interfering RNA (siRNA)–
mediated knockdown of α1 and α2 in cultured cells showed that 
PAFAH Ib α1 and α2 function to mediate the functional organiza-
tion of the Golgi complex and secretion (San Pietro et al., 2009; 
Bechler et al., 2010). These results show that PAFAH Ib has an un-
expected role in intracellular membrane trafficking. Here we show 
that this role is not limited to secretion. We found that α1 and α2 
are partially localized to endosomes and that overexpression of 
either subunit induces endosome membrane tubule formation and 
alters the recycling route of endocytosed Tf and TfRs. Conversely, 
siRNA-mediated knockdown of α1 or α2 in cultured cells inhibited 
endosome tubule formation and delayed the recycling of Tf. These 
results demonstrate a novel mechanism for mediating endosome 
membrane trafficking and a new physiological role for PAFAH Ib 
enzymes.
RESULTS
PAFAH Ib α1 and α2 are found on early-sorting endosomes 
and the endocytic recycling compartment
The intracellular location of PAFAH Ib α1 and α2 has not been 
well documented. One study found green fluorescent protein 
(GFP)–tagged α1 diffuse in the cytoplasm, in the nucleus, and on 
juxtanuclear structures that resemble the Golgi complex (Smith 
et al., 2000). We confirmed this localization pattern in cells trans-
2350 | M. E. Bechler et al. Molecular Biology of the Cell
siRNA-mediated knockdown of α1 and α2 alters the 
localization of endocytosed transferrin and delays 
transferrin recycling
To investigate the potential role of PAFAH Ib PLA2 subunits α1 and 
α2 in endocytic recycling, siRNA-mediated knockdown was con-
ducted with siRNAs targeting both α1 and α2. A large assortment of 
cell lines was found to express both α1 and α2, and therefore it was 
necessary to transfect cells with an siRNA mixture to knock down 
both proteins. In BTRD cells, the mixed siRNAs reproducibly gener-
ated >80% reduction in α1 and α2 levels (Figure 3A).
Tf trafficking in cells with reduced α1 and α2 was monitored 
over a pulse-chase time course with fluorescein isothiocyanate 
(FITC)-Tf. Within 5 min of endocytosis, the amount of FITC-Tf was 
equivalent between α1 and α2 knockdown and control cells 
(Figure 3, B and C), indicating that knockdown did not affect endo-
cytosis. Within 15 min of FITC-Tf endocytosis, there was an appar-
ent difference between knockdown and control cells. In knock-
down cells, FITC-Tf was clustered in a tight, central ERC-like 
location, with very few peripherally labeled endosomes (Figure 3, 
B and E). This became more evident by 45 min pulse. This distribu-
tion of FITC-Tf was also evident during chase of FITC-Tf out of the 
cells (Figure 3, B and E). In addition, during chase time points, α1 
and α2 knockdown cells appeared to retain total FITC-Tf fluores-
cence over a longer period of time, indicating that the recycling of 
FITC-Tf was slowed (Figure 3, B and D).
Knockdown of α1 and α2 alters the distribution 
of early and late endosomes but not the endocytic 
recycling compartment
Because the distribution of FITC-Tf was affected by α1 and α2 
knockdown, and overexpression affects the distribution of endo-
somes, we wanted to address whether the physical location of en-
dosomes was affected with the reduction of α1 and α2. Therefore 
we analyzed the distribution of early endosomes, late endosomes, 
recycling endosomes, and lysosomes in α1 and α2 knockdown 
BTRD cells. Endosomes and lysosomes labeled with either EEA1, 
CD63, or cathepsin D, but not GFP-Rab11, were more clustered in 
the cell center with reduced α1 and α2 (Figure 4A). To determine 
whether this phenotype was due to decreased α1 and α2 PLA2 ac-
tivity or a consequence of reduced binding to LIS1, which regulates 
dynein activity (Tarricone et al., 2004; Kardon and Vale, 2009), we 
expressed RNAi-resistant versions of α1 wild-type, catalytic inactive 
(α1 S47A), and binding mutants α1 E38D or α1 S47A/E38D in cells 
that were treated with α1 and α2 siRNAs. Cells expressing RNAi-
resistant α1 or α1 S47A rescued the distribution of early and late 
endosomes, as well as lysosomes. In contrast, cells expressing LIS1-
binding mutant versions displayed similar phenotypes to α1 and α2 
knockdown cells (Figure 4, B–D), suggesting that endosome cluster-
ing is a result of lost α1 and α2 interactions with LIS1.
This redistribution of endocytic markers could result from physi-
cal relocation of endosomes, mistargeting of endocytic proteins, or 
enhanced fusion of early endosomes with late endosomes. To de-
termine whether the endosome markers still appropriately localize 
to distinct early and late endosome organelles in α1 and α2 knock-
down cells, double and triple labeling with Rab proteins was con-
ducted. The reduction of α1 and α2 levels did not affect the colo-
calization of EEA1 with GFP-Rab4 or GFP-Rab5 (Supplemental 
Figure S2). Conversely, EEA1 did not localize to GFP-Rab7– or 
CD63-positive late endosomes (Supplemental Figure S2A; unpub-
lished data). In addition, CD63 did not colocalize with GFP-Rab4 
(Supplemental Figure S2A) but did colocalize appropriately with 
GFP-Rab7 (unpublished data).
FIguRE 1: Localization of α1 to early and recycling endosomes. 
(A) HA-tagged α1 (anti-HA) was expressed and partially 
colocalized with the early-sorting endosome protein GFP-Rab5 in 
BTRD cells. (B) Line fluorescence intensity plot of α1 and GFP-
Rab5 from A; line shown in the GFP-Rab5 image. (C) Cells 
expressing both α1-HA and GFP-Rab11 show that α1 colocalizes 
to the ERC. (D) Line fluorescence intensity plot of α1 and GFP-
Rab11, from the line shown in the GFP-Rab11 confocal slice of C. 
Scale bars, 10 μm. Images shown are representative of more than 
five independent experiments. (E) Purified α1 and α2 specifically 
bind to PI(3)P and PI(4)P, and PI(3)P, respectively, on protein–lipid 
overlays. Purified EEA1FYVE and FAPPPH served as positive controls 
for PI(3)P and PI(4)P binding, respectively. Chol, cholesterol; 
PA, phosphatidic acid; PC, phosphatidylcholine; 
PI, phosphatidylinositol; PS, phosphatidylserine.
Volume 22 July 1, 2011 PLA2 in endosome tubules and trafficking | 2351 
As a second test of endosome identity, 
we examined whether Tf is delivered to 
EEA1-labeled endosomes shortly after en-
docytosis. Within 5 min of internalization 
from the plasma membrane, proteins arrive 
in EEA1-labeled early endosomes but are 
not yet sorted to the ERC or late endo-
somes (Maxfield and McGraw, 2004). In 
both control and α1 and α2 knockdown 
cells, FITC-Tf internalized for 5 min colocal-
ized with a subset of EEA1-labeled puncta, 
although FITC-Tf and EEA1 puncta were lo-
cated in the center of α1 and α2 knockdown 
cells (Supplemental Figure S2C), indicating 
that Tf did reach functionally defined early 
endosomes.
PAFAH Ib α1 and α2 regulate 
endosome tubule formation
Early-sorting endosomes and the ERC are 
complex tubulovesicular organelles. At 
steady state, the tubular elements are diffi-
cult to image and quantify because they are 
highly dynamic. However, the tubular do-
mains of endosomes become greatly en-
hanced when treated with brefeldin A (BFA), 
an inhibitor of coated vesicle formation 
(Lippincott-Schwartz et al., 1991; Wood 
et al., 1991; Wood and Brown, 1992). BFA 
provides a useful tool for investigating the 
molecular mechanisms required to make tu-
bules. For example, previous studies showed 
that PLA2 antagonists inhibit BFA-stimulated 
endosome tubule formation (de Figueiredo 
et al., 2001). Therefore we asked whether 
α1 and α2 are required for BFA-stimulated 
tubule formation by performing siRNA-me-
diated knockdown experiments. In control 
cells, early endosomes and the ERC labeled 
with FITC-Tf rapidly undergo extensive tu-
bule formation after addition of BFA, whereas 
the endosomes in siRNA-treated cells dis-
played many fewer tubules (Figure 5, A–C). 
Quantification of these results revealed that 
the extent of membrane tubule formation 
was reduced in knockdown cells (Figure 5B).
To determine whether, conversely, over-
expression of α1 or α2 increased endosome 
tubule formation, we measured the percent-
age of endosomes that had tubular mor-
phology in transfected and nontransfected 
FIguRE 2: Overexpression of α1 or α2 redistributes early and late endosomes to the cell 
periphery. (A) Wide-field images of untransfected BTRD cells side by side with cells expressing 
either wild-type α1, catalytic inactive α1 
S47A, LIS1-binding mutant α1 E38D, or 
double mutant α1 S47A/E38D (HA tagged) 
and colabeled with early (EEA1), late (CD63), 
or recycling endosome (GFP-Rab11) markers. 
Asterisk indicates transfected cells. (B) 
Quantification of the percentage of cells with 
endosomes, early (EEA1) or late (CD63), 
dispersed toward the cell periphery. Scale 
bar, 10 μm.
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cells that had internalized TRITC-Tf or Alexa 
488–Tf for 45 min, which labels both early 
and recycling endosome compartments. 
Overexpression of wild-type α1 or α2 caused 
endosomes to become more tubular. Long-
axis lengths of sorting endosomes in control 
cells were 1.04 ± 0.2 μm versus 1.41 ± 0.3 μm 
in transfected cells (Figure 5D). In addition, 
the percentage of total endosomes with sin-
gle or multiple tubules was significantly in-
creased with overexpression of catalytically 
active α1 or α2 (Figure 5E). This tubule for-
mation was dependent on catalytic activity 
because overexpression of catalytic mutants 
(α1 S47A or α2 S48A) did increase the frac-
tion of tubulated endosomes. Because over-
expression of α1 or α2 influenced the distri-
bution of endosomes in an LIS1-dependent 
manner, we examined whether endosome 
tubule formation was similarly dependent. 
The results showed that overexpression of 
the catalytically active, LIS1-binding mutants 
(α1 E38D or α2 E39D) also increased endo-
some tubules, but the catalytically inactive, 
LIS1-binding double mutants did not 
(Figure 5E). These results demonstrate that 
PAFAH Ib increases endosome tubule for-
mation by virtue of its phospholipase activity 
and not through altering LIS1-dependent ef-
fects on dynein function.
Overexpression of PAFAH Ib α1 or α2 
alters trafficking through the endocytic 
recycling compartment
To investigate whether the overexpression 
of α1 and α2 may enhance endocytic traf-
ficking, we examined the effect of overex-
pressing wild-type or mutant versions of 
α1 or α2 on trafficking of Alexa 488–la-
beled Tf (Tf-488). Only α1 is shown and 
discussed here, as results for α1 and α2 
were comparable. Cells were incubated 
with media containing Tf-488 (pulse) for 
45 min, followed by replacement of 
the media with unlabeled Tf (chase) for 
40 min. The internalization of fluorescent 
Tf in 15 min was equivalent between con-
trol and all α1-overexpressing cells 
(Figure 6, A and B). Following a 45 min 
pulse of Tf-488 in untransfected cells or 
cells transfected with LIS1-binding mu-
tants α1 E38D or α1 S47A/E38D, Tf-488 
was localized to puncta throughout the 
cell, as well as clustered in the juxtanuclear 
ERC (Figure 6, A and C). However, in cells 
expressing wild-type α1 or α1 S47A, Tf lo-
calized only to puncta in the periphery. 
Similarly, TfRs were found peripherally dis-
tributed in α1 or α1 S47A-transfected 
HeLa cells, but TfR distribution was not af-
fected in cells expressing LIS1-binding 
mutant constructs (Figure 6D).
FIguRE 3: siRNA-mediated knockdown of α1 and α2 delays the recycling of transferrin. 
BTRD cells were transfected with control or α1 and α2 siRNAs 72 h before experimentation. 
(A) Western blots of BTRD cell lysates 72 h after siRNA transfection. (B) Pulse-chase 
experiments were conducted with FITC-Tf in control and α1 and α2 siRNA-treated cells. Cells 
were pulse labeled with FITC-Tf for 45 min, followed by chase in media containing unlabeled 
(nonfluorescent) Tf for 15 min. Representative confocal images are shown for the indicated time 
points. (C) Total FITC-Tf fluorescence was measured at 5 and 15 min after addition of FITC-Tf to 
the media (pulse). (D) At the indicated chase time points, Tf fluorescence remaining in cells was 
quantified and is shown as a percentage of the total Tf fluorescence after 45 min pulse 
(maximum Tf fluorescence). At 30 min, p < 0.05 by a t test. (E) The fluorescence intensity of the 
juxtanuclear, central FITC-Tf was measured at the indicated pulse and chase time points in 
control or α1 and α2 siRNA-treated cells. n = 4; error bars, SEM.
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affected the route of Tf, as fluorescent Tf never accumulated in the 
ERC (Figure 6, A–C). These results suggest that overexpression of 
α1 or α2, likely by disrupting LIS1 activation of dynein (Yamaguchi 
et al., 2007; Ding et al., 2009; Lam et al., 2010), reduced the trans-
port of Tf from peripheral early-sorting endosomes to the central 
ERC, thus bypassing the ERC during the recycling to the cell sur-
face. The overexpression of α1 E38D also did not interfere with the 
To compare Tf recycling, a chase with unlabeled Tf for 10, 20, 
or 40 min was conducted. In control cells and cells expressing 
LIS1-binding mutant versions of α1, Tf-488 accumulated in the 
central ERC; over the 40 min of chase, Tf-488 signal was progres-
sively lost due to the recycling of Tf out of the cell and its release 
into the medium (Figure 6). The overexpression of α1 or α1 S47A 
did not have an effect on the kinetics of Tf recycling, but rather 
FIguRE 4: Endosome positioning is altered in α1 and α2 knockdown cells due to lost interactions with LIS1. 
(A) Confocal images of early endosomes (EEA1), late endosomes (CD63), lysosomes (cathepsin D), the transferrin 
receptor (TfR), or recycling endosomes visualized with expression of GFP-Rab11 in BTRD cells transfected with control 
RNA or siRNA targeting α1 and α2. (B) Confocal images of α1 and α2 siRNA-treated BTRD cells transfected with 
RNAi-resistant α1, catalytic inactive α1 S47A, LIS1-binding mutant α1 E38D, or double mutant α1 S47A/E38D. Wild-type 
α1 and catalytic inactive α1 S47A rescued endosome clustering seen with α1 and α2 knockdown, but LIS1-binding 
mutant (E38D) versions did not rescue changes in endosome distribution. Asterisk indicates cells transfected with α1 
RNAi-resistant constructs, as determined by anti-HA staining. (C) Quantification of early and late endosome clustering in 
knockdown and RNAi-resistant α1 transfected cells as indicated. n = 3–4; error bars, SEM.
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DISCUSSION
These results reveal novel means for mediating endosome mem-
brane trafficking and morphology with a new functional role for 
cytoplasmic PAFAH Ib α1 and α2. Overexpression of α1 or α2 had 
three clear phenotypic consequences: 1) redistribution of early and 
late endosomes toward the cell periphery; 2) recycling of Tf/TfR 
recycling of Tf, since fluorescence of Tf-488 during chase time 
points was comparable to that of control cells (Figure 6B). There 
was, however, a noticeable lag in recycling kinetics with the double 
mutant α1 S47A/E38D. During chase time points, α1 S47A/E38D 
showed higher Tf-488 fluorescence in the cell, suggesting delayed 
recycling kinetics compared with α1 E38D and control cells.
FIguRE 5: α1 and α2 knockdown inhibits BFA-stimulated tubulation of endosomes, and overexpression of α1 or α2 
induces endosome tubule formation. (A) Cells transfected with control RNA or siRNAs against α1 and α2 were 
incubated with FITC-Tf for 45 min to label all early-sorting endosomes and the ERC, and then treated with BFA (5 μg/ml) 
in the continuous presence of FITC-Tf for the indicated times. Scale bar, 10 μm. (B) Magnified images of FITC-Tf–labeled 
endosomes in control and α1 and α2 siRNA-treated cells after 5 min of BFA treatment. (C) Quantification of BFA-
stimulated tubulation in control and α1 and α2 siRNA-treated cells. n = 4; error bars, SEM. (D) Representative images of 
control HeLa cells and HeLa cells transfected with α2. Cells were incubated with Alexa 488–Tf for 45 min to label 
endocytic compartments. Scale bar, 5 μm. (E) Percentage of endosomes with membrane tubules in control cells or cells 
transfected with indicated versions of α1 or α2. More than 35 cells and 4500 endosomes were counted per condition, 
from a total of three independent experiments. Error bars = SEM. One-way ANOVAs were conducted to evaluate 
differences between conditions. The percentages of endosomes with membrane tubules for control, α1 S47A, α1 S47A/
E38D, α2 S48A, and α2 S48A/E39D cells were not statistically different. The percentages of endosomes with membrane 
tubules for cells transfected with α1, α1 E38D, α2, or α2 E39D were all statistically different from control and 
catalytically inactive α1 and α2 counterparts with p < 0.0001 (asterisks).
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FIguRE 6: Overexpression of α1 reroutes Tf and the TfR traffic from early endosomes, bypassing the central endocytic 
recycling compartment, back to the plasma membrane, and double mutant α1 S47A/E38D slows Tf recycling. (A) HeLa 
cells were transiently transfected with α1-HA or α1 mutants and pulse labeled with Alexa 488–Tf (Tf-488) for 15 and 
45 min, followed by chase in Tf-free media for 20 or 40 min to observe Tf internalization and recycling. Scale bar, 10 μm. 
(B) The fluorescence intensity of Alexa 488–Tf was measured for pulse and chase time points in untransfected (control) 
HeLa cells and cells expressing indicated proteins. α1 S47A/E38D compared with control or compared with α1 E38D is 
significantly different, with p < 0.0001 as analyzed by a t test. (C) Quantification of the percentage of cells with central 
(ERC) Tf fluorescence after a 45 min pulse of Alexa 488–Tf (Tf-488). (D) Percentage of cells with central Tf receptor 
(anti-TfR) fluorescence. Anti-TfR was used without colabeling with anti-HA, as the antibodies were both from mice. 
Therefore cell counts include both transfected and untransfected HeLa cells. Error bars, SEM.
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plasma membrane (step B). This is an appealing possibility that fits 
well with our observations. The overexpression of α1 or α2, each of 
which can bind LIS1, appears to dramatically inhibit dynein-depen-
dent function, blocking early to recycling endosome transport (step 
C) and rerouting Tf to recycle from early endosomes to the plasma 
membrane (step B). Therefore no apparent dominant-negative phe-
notype would be seen, as the trafficking steps regulated by α1 and 
α2 would already be blocked by reduced dynein function. This sug-
gests that α1 and α2 are important for transport from early endo-
somes to the ERC (step C) and/or from the ERC to the plasma mem-
brane (step D).
We found that overexpression of α1 or α2 increased the number 
of tubulated peripheral endosomes, whereas α1 and α2 knockdown 
inhibited Tf-labeled endosome tubules. These changes in mem-
brane tubule formation can be explained by the direct membrane-
altering action of PAFAH Ib PLA2 subunits, as catalytically inactive 
forms α1 S47A or α2 S48A did not increase endosome membrane 
tubules. The conclusion that α1 and α2 work directly on endosome 
membranes is supported by fluorescence imaging showing that 
both α1 and α2 are associated with Rab5- and EEA1-positive early-
sorting endosomes and the Rab11-positive ERC. Consistent with 
these results, and with previous studies in which α1 and α2 were 
also localized to Golgi membranes, we found that α1 specifically 
interacted with endosome-enriched PI(3)P and Golgi-enriched 
PI(4)P, and α2 with PI(3)P. Of interest, neither α1 or α2 has any iden-
tifiable known PIP-binding motifs or domains, such as the FYVE 
domain of EEA1 that binds PI(3)P (Stenmark et al., 1996; Burd and 
Emr, 1998). However, the crystal structure of PAFAH Ib reveals the 
presence of a small surface cluster of basic residues (Ho et al., 1997), 
which could be functionally similar to the basic residue clusters 
used by PH and FYVE domains to bind phosphate groups of PIPs 
(Lemmon, 2008).
There is growing evidence that cytoplasmic PLA enzymes con-
tribute to the formation of membrane tubules and regulate traffick-
ing (de Figueiredo et al., 1998, 1999, 2000; Polizotto et al., 1999). 
The hydrolytic activity of α1 or α2 may contribute to the formation 
of membrane tubules by removal of sn-2–position acyl chains from 
phospholipids, resulting in a shift from cylindrical or cone-shaped 
phospholipids to inverted-cone–shaped lysophospholipids (Brown 
et al., 2003). Localized accumulation of lysophospholipids creates 
tighter packing of the acyl chains in one leaflet of the membrane 
bilayer, resulting in outward curvature of the membrane that could 
then grow into a tubule (Sheetz and Singer, 1974; Zimmerberg and 
Kozlov, 2006). Alternatively, the lipid-modifying activity of α1 and α2 
may feed into lipid-modifying pathways that can either directly af-
fect membrane curvature or act indirectly by recruiting proteins that 
bend membranes.
In recent work, three phospholipases have been shown to be 
involved in Golgi structure and function. The cytoplasmic Ca2+-de-
pendent enzyme cPLA2α was shown to be recruited to the Golgi 
following an increase in secretory load and to enhance intra-Golgi 
membrane tubules that facilitate anterograde transport through the 
Golgi stack (San Pietro et al., 2009). cPLA2α was also found to be 
required for export of junctional proteins in polarized endothelial 
cells (Regan-Klapisz et al., 2009). PLA2G6-A was shown to be re-
quired for tubule-mediated assembly of the endoplasmic reticulum-
Golgi intermediate compartment (Ben-Tekaya et al., 2010). Finally, 
in other studies, we have found that PAFAH Ib α1 or α2 is also local-
ized to the Golgi complex, where it mediates tubule formation and 
secretory trafficking (Bechler et al., 2010). These results, along with 
studies described here, establish that α1 or α2 function at multiple 
organelles.
from early-sorting endosomes to the plasma membrane, bypassing 
the ERC; and 3) stimulation of endosome tubule formation. These 
phenotypes were opposite to effects seen with loss of α1 and α2: 1) 
redistribution of early endosomes, late endosomes, and lysosomes 
to the cell center; 2) a delay in Tf recycling to the cell surface; and 3) 
inhibition of BFA-stimulated endosome tubules.
The altered organelle distribution observed by overexpression 
or knockdown of α1 and α2 could be explained by, respectively, in-
creased or decreased interactions with LIS1. This would affect the 
fraction of LIS1 available to bind and activate dynein for minus end–
directed microtubule transport (Tarricone et al., 2004; Yamaguchi 
et al., 2007). In effect, the overexpression or knockdown would de-
crease or increase, respectively, transport of endosomes and lyso-
somes toward the centrosome, which is a dynein-dependent func-
tion activated by LIS1 (Burkhardt et al., 1997; Harada et al., 1998; 
Liang et al., 2004; Lam et al., 2010). Our results are in agreement 
with reports that overexpression of α1 and α2 affect LIS1 binding 
and regulation of dynein in endosome and lysosome transport (Ding 
et al., 2009).
The effects of α1 and α2 overexpression and knockdown on Tf 
recycling may be partially explained by interactions with LIS1. Pulse-
chase experiments demonstrate that overexpression of wild-type 
and catalytically inactive α1 and α2 prevent transport of Tf from 
peripheral early-sorting endosomes to the ERC (Supplemental 
Figure S3, step C) but not the release of internalized Tf from the 
cell. These results strongly suggest that Tf is recycled directly from 
early-sorting endosomes rather than from the ERC (Supplemental 
Figure S3, step B). In fact, a portion of the endocytosed membrane 
and receptors are normally recycled from early-sorting endosomes 
directly back to the plasma membrane (Sheff et al., 1999; Hao and 
Maxfield, 2000). This apparent rerouting of Tf and TfR did not occur 
with the overexpression of LIS1-binding-defective constructs, 
strongly suggesting that Tf and TfR may be shuttled directly from 
early endosomes to the plasma membrane due to decreased dy-
nein activation by LIS1. This indicates that dynein activation by LIS1 
is important for transport from early endosomes to the endocytic 
recycling compartment, a trafficking step that is dynein dependent 
and membrane tubule mediated (Maxfield and McGraw, 2004; 
Driskell et al., 2007; Traer et al., 2007). These results are reminiscent 
of dynein inactivation by the overexpression of dynamitin, which 
also shifts the route of Tf recycling directly from peripherally sorting 
endosomes but does not affect the kinetics of recycling (Valetti 
et al., 1999). The binding of LIS1 by excess α1 or α2 (from overex-
pression) would decrease the activation of dynein-mediated trans-
port of cargo, including Tf transport from the early-sorting endo-
somes to the ERC (Supplemental Figure S3C).
The catalytically inactive LIS1-binding mutant, α1 S47A/E38D, 
did not reroute Tf but did delay Tf recycling compared with control 
cells and α1 E38D-overexpressing cells. This catalytically inactive 
mutant (α1 S47A/E38D) may act as a dominant negative, which has 
been suggested by recent studies (Bechler et al., 2010). Catalytically 
inactive subunits may dimerize with endogenous subunits, creating 
inactive, “poisoned” dimers. A dominant-negative effect by the 
catalytic mutant is consistent with knockdown experiments, which 
also showed a delay in Tf recycling. If catalytically inactive α1 (S47A) 
or α2 (S48A) acts as a dominant negative, one would predict that α1 
S47A would also delay Tf recycling. A possible explanation to this 
apparent inconsistency is depicted in Supplemental Figure S3: α1 
and α2 are important for membrane trafficking from early endo-
somes to recycling endosomes (step C) and/or from the ERC to the 
plasma membrane (step D) but not necessarily in the “short” recy-
cling pathway directly from the early-sorting endosomes to the 
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Our studies identify a specific cytoplasmic PLA2, PAFAH Ib, that 
is capable of inducing membrane tubule formation and altering en-
docytic membrane trafficking pathways. Furthermore, these results 
demonstrate a physiological role for PAFAH Ib in mediating intracel-
lular membrane trafficking. Although it is possible that some effects 
of PAFAH Ib on endosomes are indirectly caused by α1- and α2-
mediated changes in Golgi function (the converse is possible as 
well), our experiments cannot resolve this issue. Future research 
should further address how PAFAH Ib selectively interacts with 
endosome and Golgi membranes and whether it interacts with other 
molecules, for example, Rabs, sorting nexins, and phosphoinositi-
des, to facilitate efficient endosomal sorting. Nevertheless, this work 
and the recent work of others demonstrate the importance of lipid-
modifying enzymes in both secretory and endocytic trafficking.
MATERIALS AND METHODS
Materials and reagents
Brefeldin A was obtained from BIOMOL Research Laboratories (Enzo 
Life Sciences, Plymouth Meeting, PA). Stock solutions of BFA (in etha-
nol) were stored at −20°C and diluted to working concentrations just 
before use. Tetramethylrhodamine-conjugated transferrin (TRITC-Tf), 
Alexa 488–conjugated human transferrin (Tf-488), and bovine holo 
transferrin were purchased from Invitrogen (Carlsbad, CA). Fluores-
cein isothiocyanate was from Sigma-Aldrich (St. Louis, MO).
We prepared guinea pig polyclonal anti-α1 antibodies, pur-
chased chicken anti-α2 (Abcam, Cambridge, MA), and received rab-
bit polyclonal anti-dynamin antibodies from M. McNiven (Mayo 
Clinic, Rochester, MN) for Western blot analyses. Unfortunately, 
these antibodies have not been useful for immunofluorescence. 
Mouse monoclonal anti–human influenza virus hemagglutinin was 
purchased from Covance (Berkeley, CA). Rabbit polyclonal anti–
early endosomal antigen 1 (EEA1) was purchased from ABR Affinity 
BioReagents (Golden, CO) and Cell Signaling Technology (Beverly, 
MA). Mouse anti–human transferrin receptor was obtained from 
Zymed (Invitrogen). Rabbit polyclonal antibodies against the late 
endosome/lysosome marker CD63 and lysosomal marker cathepsin 
D were prepared and characterized as described (Park et al., 1991; 
Heller et al., 1994). The secondary fluorescent antibodies goat anti-
mouse or goat anti-rabbit conjugated to FITC, TRITC, Cy5, or 
DyLight were purchased from Jackson ImmunoResearch Laborato-
ries (West Grove, PA). The anti-mouse conjugated to Alexa Fluor 
488 was from Molecular Probes (Invitrogen). Horseradish peroxidase 
(HRP)–conjugated antibodies were as follows: goat anti-chicken 
(Aves Labs, Tigard, OR), anti–guinea pig (Pocono Rabbit Farm and 
Laboratory, Canadensis, PA), and anti-rabbit (GE Healthcare Biosci-
ences, Piscataway, NJ). Human cDNA of Rab11 and Rab4 in pEGFP 
vectors, GFP-Rab11, and GFP-Rab4 were the kind gifts of M. 
Scidmore (Cornell University, Ithaca, NY). Human Rab5A cDNA in 
the pGreenLantern vector GFP-Rab5 was the gift of C. Roy 
(Yale University, New Haven, CT).
Preparation of plasmids for mammalian expression
PAFAH Ib α1-HA and α2-HA were constructed by inserting internal 
HA tags at G165 and P130, respectively. The HA tags were inserted 
by PCR, using pUC-PL-cI-α1 and pUC-PL-cI-α2 as templates. pEGFP-
N1 from BD Biosciences Clontech (Mountain View, CA) was digested 
with EcoRI and XbaI to remove the GFP gene and generate pEN1. 
The PCR fragments encoding α1-HA and α2-HA were ligated into 
EcoRI/XbaI–digested pEN1 to generate pEN1-α1-HA and pEN1-
α2-HA. pEN1-α2-S48A-HA was constructed by site-directed muta-
genesis of a single nucleotide. RNAi-resistant pEN1-α1-HA and 
pEN1-α1-S47A-HA were generated by making two silent mutations 
in the double-stranded RNA target sequence. LIS1-binding mutants 
α1 E38D or α2 E39D (Yamaguchi et al., 2007) were generated by 
site-directed mutagenesis of RNAi-resistant pEN1-α1-HA, pEN1-
α2-HA, pEN1-α1-S47A-HA, and pEN1-α2-S48A-HA.
Cell culture, transfection, and immunocytochemistry
Human epithelial (HeLa) cells and transformed bovine testicular 
(BTRD) cells were grown in modified Eagle’s minimal essential me-
dium (MEM) with 10% Nu-Serum or 10% bovine growth serum from 
Life Technologies (Carlsbad, CA) or Thermo Scientific HyClone 
(Logan, UT). All cells were maintained at 37°C in a humidified atmo-
sphere of 95% air, 5% CO2.
HeLa and BTRD cells were transfected using Lipofectamine 2000 
(Invitrogen). Cells were grown on glass coverslips for 1–2 d before 
experimentation. Lipofectamine 2000 was used as described in the 
manufacturer’s protocol with modifications: one-fourth of the listed 
DNA and transfection reagent were used, as higher quantities re-
sulted in cell death. Transfection efficiencies of 50–80% were possi-
ble with this alteration. Cells were used for experimentation 24–48 h 
after addition of the transfection mix.
For RNAi, cells were transfected on two consecutive days with 
Lipofectamine RNAiMax (Invitrogen) and 30 nM of double-stranded 
RNAs. RNAs were designed through Thermo Scientific (Dharmacon) 
custom siRNA oligo service to target bovine α1 mRNA and bovine 
α2 mRNA. The sense oligonucleotide sequences are AGAAUGGA-
GAGCUGGAACAUU and GGAGAACUGGAGAAUAUUAUU for α1 
and α2, respectively. Control duplex RNA (siControl) sequences 
were verified by the Basic Local Alignment Search Tool to have no 
significant identity to any other sequence in the bovine genome: 
siGenome nontargeting siRNA #1 and #2. Cells were used for ex-
periments 72 h after the initial RNA transfection.
Cells were processed for indirect immunofluorescence as de-
scribed (de Figueiredo et al., 2001). Primary antibodies were used at 
the following dilutions: monoclonal anti-HA at 1:100; polyclonal 
anti-EEA1 at 1:100; monoclonal anti-TfR at 1:200; polyclonal anti-
CD63 at 1:200; polyclonal rabbit anti–cathepsin D at 1:200. Second-
ary antibodies were used at the following dilutions: FITC-, TRITC-, or 
Cy5-labeled anti–mouse immunoglobulin G (IgG) or anti–rabbit IgG 
at 1:100; Alexa 488–labeled anti–mouse IgG at 1:500; and DyLight 
anti-rabbit at 1:100. Coverslips were mounted with Vectashield 
mounting media (Vector Laboratories, Burlingame, CA) and stored 
at −20°C until imaged.
Cell lysates and immunoblotting
Cells were lysed by scraping dishes in the presence of 0.05% Triton 
X-100 in phosphate-buffered saline, pH 7.4, and complete protease 
inhibitor cocktail (Roche Applied Science, Mannheim, Germany). 
Lysates and purified proteins were run by SDS–PAGE, transferred to 
PVDF membranes, and Western blotted with the antibodies guinea 
pig anti-α1 (1:2000) and chicken anti-α2 (1:1000), and rabbit anti-
dynamin (1:10,000) was used as an internal loading control. HRP-
conjugated antibodies were goat anti-guinea pig (1:2500), goat 
anti-chicken (1:2500), and goat anti-rabbit (1:10,000). HRP was de-
tected with Millipore (Billerica, MA) enhanced chemiluminescent 
reagent. Band intensities were quantified using ImageJ software 
(National Institutes of Health, Bethesda, MD), and background in-
tensity was subtracted and normalized to the corresponding anti-
dynamin band for each lane.
Lipid-protein overlays
Stock lipids (Avanti Polar Lipids, Alabaster, AL) and PIPs (Cell Signal-
ing Technology, Beverly, MA) in chloroform were diluted with 
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spotting buffer (1:1 chloroform:methanol with 0.2% Ponceau S stain) 
to yield 100–500 pmol/ml. One milliliter of lipids or PIPs was spotted 
onto Whatman BAS-85 nitrocellulose membranes and dried for 1 h 
at room temperature in the dark. After incubating the membranes 
with 1–10 μg/ml of purified protein in Tris-buffered saline and 0.1% 
Triton X-100 with 0.2% fatty acid–free bovine serum albumin over-
night at 4°C, membranes were washed and subsequently processed 
using standard immunoblotting procedures.
Transferrin preparation and trafficking experiments
For use in BTRD cell experiments, bovine holo transferrin was conju-
gated to FITC as described (McGraw and Subtil, 1999). Alexa 
488–labeled human Tf (Molecular Probes, Invitrogen) was used for 
HeLa cell experiments. For Tf uptake experiments, HeLa cells or 
BTRD cells were grown on coverslips for a minimum of 2 d, washed 
15 min three times in 37°C MEM or DMEM without serum, and in-
cubated for the indicated pulse time points with 40 μg/ml fluores-
cent holo Tf in 37°C MEM or DMEM. Cells were then washed three 
times in 37°C MEM + 10% bovine growth serum or Nu-Serum, with 
subsequent incubation for chase time points.
Microscopy
Wide-field epifluorescence imaging was done using a Zeiss Axio-
scope II, with Zeiss 40x or 100x Plan-Apochromat numerical aper-
ture–1.4 objective lenses, a Hamamatsu Orca II digital camera, and 
Openlab software (Improvision, PerkinElmer, Waltham, MA). Spin-
ning disk confocal images were taken with a Nikon Eclipse TE2000-
U, Nikon Plan-Apo 60xA/N1.4, or Nikon Plan-Apo100x/N1.4 oil 
objective, with PerkinElmer UltraVIEW LCI, a Hamamatsu 1394 
ORCA-ER camera, and PerkinElmer UltraVIEW software.
Image analysis and statistics
For Tf trafficking analysis, Tf fluorescence was measured from 40× 
Zeiss wide-field images using ImageJ to measure total cell fluores-
cence intensity, central (ERC) fluorescence intensity, and background 
fluorescence. For each image, the background fluorescence inten-
sity (per pixel) was subtracted from the corresponding cell fluores-
cence measurements. Total Tf fluorescence corresponds to the total 
cell fluorescence, percentage of maximum Tf fluorescence corre-
sponds to the total cell fluorescence at the indicated time point as a 
percentage of total cell fluorescence after 45 min of Tf pulse, and 
the center Tf fluorescence corresponds to the fluorescence of clus-
tered juxtanuclear Tf fluorescence signal. ERC markers could not be 
used, as the markers were not compatible with other fluorescence 
and immunolabeling used.
For determining the percentage of cells with a particular distribu-
tion of early and late endosomes, cells with endosomes present or 
absent in the juxtanuclear region of the cell were qualitatively 
counted “blind” (i.e., not knowing the experimental condition). 
Similar qualitative analysis was conducted for determining percent-
age of cells with central TfR or Tf, where cells were counted for hav-
ing or lacking a distinct central, juxtanuclear fluorescence spot.
To determine the percentage of endosomes with tubules, Alexa 
488–Tf-labeled endosomes (100–370/cell) were counted from two 
confocal slices 0.4 μm apart, starting 0.8 μm from the cell surface 
adjacent to the coverslip. Endosomes were counted as spherical (no 
tubules), with one tubule or with multiple tubules. Tubules were de-
fined as elongated protrusions.
Error bars on graphs represent SE of the mean values for a mini-
mum of 100 cells and a minimum of three independent experiments, 
unless otherwise specified. Two-tailed, unequal variance Student’s t 
tests or analyses of variance (ANOVAs) were used to determine 
significance.
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